Dramamine news and resources

Latest News

Great Lakes Cities Tackle Pharmaceutical Pollution - WXXI
Great Lakes Cities Tackle Pharmaceutical PollutionWXXI, NYROCHESTER, NY (WXXI) - An association representing cities around the Great Lakes is demanding the United States and Canada move to keep chemicals from pharmaceuticals out of the water supply. The Great Lakes and Saint Lawrence Cities Initiative is.

Pharmaceuticals Aren't Homeopathic - Seattle Post Intelligencer
Washington PostPharmaceuticals Aren't HomeopathicSeattle Post IntelligencerPharmaceutical ingredients are not the source of homeopathic remedies for the vast majority of existing remedies. But then AP isn't disclosing their information source here. Ethical manufacturers of classical homeopathic remedies do not order source.Homeopathy, conventional drugs share ingredients The Associated Pressall 122 news articles

Oracle Adds To Its Health Sciences Portfolio - InformationWeek
CXOToday.comOracle Adds To Its Health Sciences PortfolioInformationWeek, NYThe database giant is acquiring the intellectual property of Conformia, maker of software used in the production of chemical, biotechnology, and pharmaceutical products. By Charles Babcock Oracle Wednesday acquired the intellectual property assets of.Oracle Acquisition Expands PLM Offerings ChannelWebLatest Oracle Acquisition to Bolster Life Sciences Push Managing Automation MagazineOracle Acquires Intellectual Property Assets Of Conformia Software. RTT NewsPR Newswire (press release) - Bizjournals.comall 44 news articles

Pharmaceutical Companies Are Ready For The H1N1 Influenza Pandemic - Medical News Today (press release)
CTV.caPharmaceutical Companies Are Ready For The H1N1 Influenza PandemicMedical News Today (press release), UKWhen the novel H1N1 outbreak began, vaccine and pharmaceutical manufacturers began their own internal preparations to respond to the situation. Measures undertaken included preparing to produce a targeted novel H1N1 vaccine and increasing the.Video: Swine flu in India: 2 confirmed cases in Bangalore NDTV.comH1N1 virus - an early perspective Little Chicago ReviewOne case of swine flu reported in Homer Homer NewsBusiness Standardall 1,929 news articles

China Set to Grant Approval for First IPO Since Sept. - Bloomberg
China Set to Grant Approval for First IPO Since Sept.BloombergGuilin Sanjin Pharmaceutical Co., Zhejiang Wanma Cable Co. and Shenzhen Salubris Pharmaceuticals Co. are the three candidates for getting written permission to sell stock in Shenzhen, the people said, declining to be identified because they aren't.Guilin Sanjin set to be China's 1st IPO in 10 mths ForbesBeijing sets stage for resuming IPOs Financial TimesChina's Stock Exchanges Revise IPO Subscription Rules Wall Street JournalAlibaba News Channel - Wall Street Journalall 12 news articles

Teva Is Ready for Major Acquisition, Chief Says - Bloomberg
Teva Is Ready for Major Acquisition, Chief SaysBloombergBy Naomi Kresge June 18 (Bloomberg) -- Teva Pharmaceutical Industries Ltd., which bought Barr Laboratories Inc. for $7.4 billion last year, is ready for another “major” acquisition and may look beyond generic drugs for the purchase, Chief Executive.Teva's Yanai: We're ready for another big acquisition GlobesTeva on the hunt for 'major' acquisition FiercePharmaTeva on lookout for another major acquisition, CEO says SmartBriefArutz Shevaall 5 news articles

Savient Pharm Rises On Krystexxa Panel Recommendation - Wall Street Journal
Dog Flu Diet and DiseasesSavient Pharm Rises On Krystexxa Panel RecommendationWall Street JournalBy Alexandra Scaggs Of DOW JONES NEWSWIRES Savient Pharmaceuticals, Inc. (SVNT) jumped more than 35% a day after a Food and Drug Administration panel backed approval of one of its drugs in development. An FDA panel voted 14 to 1 to recommend approval.FDA Panel Recommends Approval of a Gout Drug New York TimesDrug stocks climb; Savient rallies on FDA move MarketWatchSavient On A Sprint With Positive Tidings On Gout Drug – Stocks To. RTT NewsNew York Timesall 166 news articles

Watson Makes $1.75B Generics Deal To Stay Competitive - Wall Street Journal
NJ.comWatson Makes $1.75B Generics Deal To Stay CompetitiveWall Street JournalThe deal comes as generic drug companies are applying increased pressure to the branded pharmaceutical sector, which faces patent expirations on many top-selling products in coming years. But size matters in the generic industry, which is driven by.Watson to Acquire Arrow Group for $1.75 Billion BloombergWatson to acquire Arrow Group for $1.75 billion MarketWatchWatson Buy of Arrow Could Be Rx for NJ GlobeSt. comRTT News - domain-Ball 232 news articles

Reese Witherspoon proves a "Pharm Girl'" at heart - Reuters
MSN IndonesiaReese Witherspoon proves a "Pharm Girl'" at heartReutersBy Steven Zeitchik LOS ANGELES (Hollywood Reporter) - Reese Witherspoon is going into the pharmaceutical business with Universal Pictures. The studio is developing "Pharm Girl," an aspirational comedy centering on one woman's odyssey through the drug.Witherspoon prescribed 'Pharm Girl' AFPWitherspoon Getting Into the Prescription Drug Business (On Screen) BuzzSugar.comReese Witherspoon is a Drug Dealing 'Pharm Girl' MTV.comEntertainment Weekly - Nature.com (subscription)all 44 news articles

Molecular Insight Pharmaceuticals Has Risen Above Today's Range - RTT News
Molecular Insight Pharmaceuticals Has Risen Above Today's RangeRTT News, NY6/18/2009 10:26:12 AM(RTTNews) Molecular Insight Pharmaceuticals (MIPI) gapped open higher Thursday, but has since moved in a narrow range. The stock has climbed in the last 10 minutes on increased volume and is now up 1.08 at $7.32..SOURCE: Molecular Insight Pharmaceuticals, Inc. Market Wire (press release)Molecular Insights surge on imaging data; biosante trial to continue; FierceBiotechall 29 news articles


Copyright © 2007, search4drug.net. All Rights Reserved.

Valid XHTML | CSS